@article{article, title  = {{Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology}},

 publisher = {{Europa Digital & Publishing}},

 url = {{https://doi.org/10.4244/eij-e-26-00003 }},

 year = {{2026}},

 month = {{6}},

 author = {{Gorog DA and ten Berg JM and Campo G and Geisler T and Gigante B and Grove EL and Halvorsen S and Huber K and Jeong Y-H and Lip GYH and Navarese EP et al}},

 doi = {{10.4244/eij-e-26-00003}},

 volume = {{22}},

 journal = {{EuroIntervention}},

 issue = {{12}},

 pages = {{e653-e677}},

 note = {{Accessed on 2026/07/16}}}